BMS and AbbVie’s myeloma drug Empliciti gains approvalMultiple myeloma, one of the fastest-moving therapy areas, has just added another new treatment following FDA approval of Share XBMS and AbbVie’s myeloma drug Empliciti gains approvalhttps://pharmaphorum.com/news/bms-and-abbvie-s-myeloma-drug-empliciti-gains-approval/
